Mark Jit to Adult
This is a "connection" page, showing publications Mark Jit has written about Adult.
Connection Strength
0.112
-
Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries. Elife. 2021 06 24; 10.
Score: 0.016
-
Understanding differences in cervical cancer incidence in Western Europe: comparing Portugal and England. Eur J Public Health. 2018 04 01; 28(2):343-347.
Score: 0.013
-
Projecting social contact matrices in 152 countries using contact surveys and demographic data. PLoS Comput Biol. 2017 Sep; 13(9):e1005697.
Score: 0.012
-
Characterizing measles transmission in India: a dynamic modeling study using verbal autopsy data. BMC Med. 2017 08 10; 15(1):151.
Score: 0.012
-
Impact and Cost-effectiveness of Selective Human Papillomavirus Vaccination of Men Who Have Sex With Men. Clin Infect Dis. 2017 03 01; 64(5):580-588.
Score: 0.012
-
Thirty years of vaccination in Vietnam: Impact and cost-effectiveness of the national Expanded Programme on Immunization. Vaccine. 2015 May 07; 33 Suppl 1:A233-9.
Score: 0.010
-
The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation. Lancet Infect Dis. 2021 07; 21(7):962-974.
Score: 0.004
-
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021 04 09; 372(6538).
Score: 0.004
-
Response strategies for COVID-19 epidemics in African settings: a mathematical modelling study. BMC Med. 2020 10 14; 18(1):324.
Score: 0.004
-
Caregiver and service provider vaccine confidence following the Changchun Changsheng vaccine incident in China: A cross-sectional mixed methods study. Vaccine. 2020 10 14; 38(44):6882-6888.
Score: 0.004
-
Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat Med. 2020 08; 26(8):1205-1211.
Score: 0.004
-
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob Health. 2020 08; 8(8):e1003-e1017.
Score: 0.004
-
Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial). BMC Med Res Methodol. 2018 11 06; 18(1):125.
Score: 0.003
-
Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs. Vaccine. 2018 08 06; 36(32 Pt A):4806-4815.
Score: 0.003
-
The impact of influenza on the health related quality of life in China: an EQ-5D survey. BMC Infect Dis. 2017 10 16; 17(1):686.
Score: 0.003
-
Modelling multi-site transmission of the human papillomavirus and its impact on vaccination effectiveness. Epidemics. 2017 12; 21:80-87.
Score: 0.003
-
Social contact patterns relevant to the spread of respiratory infectious diseases in Hong Kong. Sci Rep. 2017 08 11; 7(1):7974.
Score: 0.003